Board Meeting Details

The Board of Directors meeting was held on August 07, 2026, commencing at 2:00 PM IST and concluding at 3:45 PM IST.

Key Decisions Approved

1. Financial Results Approval

The Board approved:

  • Unaudited Standalone Financial Results for quarter ended June 30, 2026
  • Unaudited Consolidated Financial Results for quarter ended June 30, 2026
  • Limited Review Report by statutory auditors

2. Director Appointment

The Board appointed Ms. Radha Chauhan as Additional Director in the category of Non-Executive Independent Woman-Director:

  • Effective from date of allotment of Director Identification Number (DIN)
  • Term: 5 consecutive years
  • Subject to allotment of DIN and shareholder approval

Director Profile Details (Ms. Radha Chauhan)

  • Graduate from Delhi University
  • Over 20 years of working experience in Pharma industry
  • Not related to any existing directors of the Company
  • Not debarred from holding director office pursuant to any SEBI Order
  • Not holding any shares in the company

Financial Performance (Standalone - Quarter ended June 30, 2026)

Income Statement (₹ in Lacs)

  • Revenue from operations: ₹10,936.96
  • Other income: ₹89.12
  • Total Income: ₹11,026.08
  • Total Expenses: ₹10,339.49
  • Profit before tax: ₹686.59
  • Tax expense: ₹199.71 (Deferred tax charge)
  • Profit for the period: ₹486.88
  • Other Comprehensive Income: ₹1.83
  • Total Comprehensive Income: ₹488.71

Key Metrics

  • Paid up Equity Share Capital: ₹1,332.00 lacs (Face value ₹10 each)
  • Basic EPS: ₹0.37
  • Diluted EPS: ₹0.37

Segment Performance (Manufacturing)

  • Segment Revenue: ₹10,936.96 lacs
  • Segment Results: ₹742.27 lacs
  • Segment Assets: ₹33,337.78 lacs
  • Segment Liabilities: ₹22,231.19 lacs

Financial Performance (Consolidated - Quarter ended June 30, 2026)

Income Statement (₹ in Lacs)

  • Revenue from operations: ₹10,936.96
  • Other income: ₹89.12
  • Total Income: ₹11,026.08
  • Total Expenses: ₹10,339.67
  • Profit before tax: ₹686.41
  • Tax expense: ₹199.71
  • Profit for the period: ₹486.70
  • Other Comprehensive Income: ₹1.83
  • Total Comprehensive Income: ₹488.53

Key Metrics

  • Basic EPS: ₹0.37
  • Diluted EPS: ₹0.37

Comparative Performance

Standalone Quarterly Comparison (₹ in Lacs)

| Particulars | Jun-26 | Mar-26 | Jun-25 |

| Revenue | 10,936.96 | 7,053.84 | 13,379.54 |

| Net Profit | 486.88 | 217.66 | 664.82 |

| EPS (₹) | 0.37 | 0.16 | 0.50 |

Trading Window Closure

The trading window for dealing in securities remained closed up to 48 hours from conclusion of the Board meeting as per SEBI (Prohibition of Insider Trading) Regulations, 2015.

Financial Statement Certification

Company submitted certificate pursuant to Regulation 33(2)(a) confirming that financial statements do not contain any false or misleading statements or figures.

Critical Notes to Financial Results

1. Trade Receivables Issues

  • Company initiated proceedings under Section 9 of IBC against Nexus Commosales Private Limited before NCLT Kolkata Bench (C.P. (IB)/13(KB)2026)
  • Trade receivables outstanding: ₹10,236.29 lacs
  • Provision made: ₹3,924.43 lacs
  • Net outstanding: ₹6,311.86 lacs
  • Management classified as non-current as amount not expected to be recovered in next 12 months

2. One Time Settlement with Prudent ARC

  • Settlement amount payable till December 2026
  • ₹2,300.00 lacs shown as current liabilities

3. SEBI Order

  • SEBI passed final order on June 30, 2026 (Order No WTM/AS/IVD-2/ID16/32460/2026-17)
  • Imposed certain restrictions/penalties
  • Company filed appeal before SAT challenging penalty and restriction
  • No liability recorded as management believes order is untenable

4. Real Estate Project Dispute

  • Company promoted Affordable Residential Plotted Colony under DDJAY Scheme (Haryana RERA Registration No. HRERA-PKL-FBD-416-2023)
  • Entered Builder Buyer Agreement with Udayanchal Leasing & Export Pvt. Ltd. in March 2023 for 107 Plots and 44 Commercial Shops (Total consideration: ₹4,928.43 lacs)
  • Agreement revoked in August 2025 due to non-receipt of payments
  • Case filed before Hon'ble Additional District Judge, Faridabad (pending adjudication)

5. Labour Code Implementation

  • Government notified four Labour Codes on November 21, 2025
  • Company assessing financial impact due to changes in regulations
  • Will consider restructured compensation of employees in current financial year

Auditor's Qualified Opinion

Statutory auditors NKSC & Co. issued qualified opinion highlighting:

Basis for Qualified Opinion

1. Company classified investments in unquoted equity shares as FVTOCI but hasn't obtained/carried out fair valuation

2. Company hasn't used expected credit loss model to assess impairment on trade receivables as required by Ind AS 109

3. Company had transactions with Amrapali Group - Supreme Court directed deposit of ₹16,700 lacs (December 2019)

  • Company filed application to accept title deeds of immovable properties worth ₹16,897 lacs net of incumbency
  • Charged ₹1,500 lacs in FY 2019-20 but neither provided liability nor shown contingent liability as required by Ind AS 37

Emphasis of Matter

1. Classification of disputed trade receivables as non-current (₹6,311.86 lacs net of provision)

2. SEBI final order imposing restrictions/penalties - no liability recorded

3. Assets held for sale amounting to ₹1,865.31 lacs against which advances of ₹4,011.36 lacs received

Subsidiary Information

Consolidated results include three subsidiaries:

  • Strawberry Star India Private Limited
  • Bihariji Highrise Private Limited
  • Bihariji Properties Private Limited
  • Subsidiaries contributed revenues of ₹0.00 lacs, net loss of ₹(0.18) lacs for the quarter
  • Subsidiary financial results not reviewed by their auditors

Availability of Results

Results available on company website www.mauria.com and BSE website www.bseindia.com